SCHEMBL23579228

SCHEMBL23579228

COC1CCN(C(=O)OC(C)(C)C)CC1(C)O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.44
▸ RECQL P46063 1/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ GPR119 Q8TDV5 5/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ PTPN6 P29350 1/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ STS P08842 1/20 0.37
▸ PDE4B Q07343 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29958797 1.00 HPGD (0.44) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL14671914 0.88 HPGD (0.47) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL15105073 0.88 HPGD (0.47) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL14671917 0.88 HPGD (0.47) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL17517752 0.85 NR1H2 (0.41) HPGDRECQLUSP2SMN1; SMN2EPHX2
SCHEMBL23578918 0.84 HPGD (0.43) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL23817330 0.82 HPGD (0.44) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL23578969 0.82 HPGD (0.44) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL21111211 0.82 HPGD (0.44) HPGDRECQLEPHX1USP2SMN1; SMN2
SCHEMBL16653187 0.82 HPGD (0.47) HPGDRECQLEPHX1USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 — — EP disclosed
CN-115135642-A Inhibitors of mutant forms of EGFR 缆图药品公司 2022-09-30 — — CN disclosed
WO-2021133809-A1 INHIBITORS OF MUTANT FORMS OF EGFR BLUEPRINT MEDICINES CORPORATION (US) 2021-07-01 — — WO disclosed
Send feedback